5-LOX-IN-2

Research use only, not for human use.

5-LOx-in-2 is a 5-lipoxygenase inhibitor (5-LOX) with an IC50 value of 0.33 μM. 5-lox-in-2 inhibits 5-LOX action IN a dose-dependent manner.

5-LOX-IN-2, an inhibitor of 5-lipoxygenase (5-LOX) with an IC50 of 0.33 μM, inhibits 5-LOX in a dose-dependent manner . 5-LOX-IN-2, reduces the cell viability of renal cancer cells and induces apoptosis, can be used for cancer research.

Cell Viability AssayCell Line:RCC4, RCC10, 786.0 cells Concentration:0-100 μM Incubation Time:4 days Result:Reduced the cell viability of renal cancer cells and was more selective toward RCC4 and 786.0 cells which are deficient for the Von Hippel-Lindau (VHL) tumor suppressor gene.Western Blot Analysis Cell Line:RCC4, RCC10, 786.0 cells Concentration:0-10 μM Incubation Time:24 hours Result:Increased in LC3B and p62 expression, blocked of the autophagic flux in RCC4 cells. Stimulated in a dose ependent manner the cleavage of pro-caspase-3 only in the RCC4 cells which lack the VHL tumor suppressor.

——

——

Immunology/Inflammation

Lipoxygenase

Lipoxygenase | Apoptosis

——

——

179691-97-5

284.31

C17H16O4

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (351.73 mM; Ultrasonic )

C(=C/C(OCCC1=CC=CC=C1)=O)\C2=C(O)C=CC(O)=C2

——

(-20℃)

With Ice Pack

≥ 2 years